HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Michael J. Bates Emily Farkas P. Michael McFadden Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bates, M. J. Articles by McFadden, P. M. Search for Related Content PubMed PubMed Citation Articles by Bates, M. J. Articles by McFadden, P. M. Related Collections Lung - other

---

Original Articles: General Thoracic

Pulmonary Resection of Metastatic Hepatocellular Carcinoma After Liver Transplantation

^a Department of Cardiothoracic Surgery, Ochsner Clinic Foundation, New Orleans, Louisiana
^b Department of Pulmonary Medicine, Ochsner Clinic Foundation, New Orleans, Louisiana

Accepted for publication October 18, 2007.

^_* Address correspondence to Dr Bates, Department of Cardiothoracic Surgery, Falk Cardiothoracic Research Center, 300 Pasteur Drivem Stanford, CA 94305-5407 (Email: mbates{at}stanford.edu).

Background: The primary limitation to long-term survival after liver transplantation for hepatocellular carcinoma (HCC) is tumor recurrence. Pulmonary resection for metastatic HCC prolongs survival in patients after liver resection; this success may be extrapolated to the transplant population in the treatment of pulmonary recurrence of HCC after liver transplantation.

Methods: Between January 2000 and January 2006, five patients who underwent orthotopic liver transplantation for HCC were identified on routine follow-up with pulmonary metastases. They all underwent resection of the pulmonary recurrence of HCC and were studied retrospectively.

Results: The time from transplant to diagnosis of pulmonary recurrence ranged from 150 days to 880 days, with a mean of 500 days. All of the recurrences were amenable to complete resection. Two patients developed a second tumor. One patient had a new primary of squamous cell carcinoma. Another patient had a bony recurrence of HCC in the ninth rib. Four of the patients are still alive, and the fifth died from hepatic failure. The stage of the tumor in the explanted liver ranged from II to IVb. The average time for survival from transplant was 44 months, and the average time from pulmonary resection was 27.5 months.

Conclusions: The patients in this study demonstrate survival times similar to patients with HCC treated with liver resection. Although the size of the study population is small, the long survival times in the patients is encouraging. The advanced stage and histologically invasive nature of the primary tumors may predispose to subsequent pulmonary recurrence.

This article has been cited by other articles:

				F. Shoji, D. Kawano, T. Ikegami, Y. Soejima, A. Taketomi, T. Yano, and Y. Maehara Surgical resection of pulmonary malignant tumors after living donor liver transplantation. Ann. Thorac. Surg., July 1, 2009; 88(1): 206 - 211. [Abstract] [Full Text] [PDF]

				C. Zhang, J. Rao, Z. Tu, and Y. Ni Surgical resection of resectable thoracic metastatic hepatocellular carcinoma after liver transplantation J. Thorac. Cardiovasc. Surg., July 1, 2009; 138(1): 240 - 241. [Full Text] [PDF]